nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—ORM1—Vandetanib—thyroid cancer	0.253	0.354	CbGbCtD
Desipramine—HTR2C—Sorafenib—thyroid cancer	0.105	0.148	CbGbCtD
Desipramine—CYP2B6—Sorafenib—thyroid cancer	0.0654	0.0917	CbGbCtD
Desipramine—CYP2C19—Sorafenib—thyroid cancer	0.0415	0.0583	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—thyroid cancer	0.0397	0.0556	CbGbCtD
Desipramine—CYP1A2—Sorafenib—thyroid cancer	0.0383	0.0538	CbGbCtD
Desipramine—ABCB1—Sorafenib—thyroid cancer	0.0335	0.047	CbGbCtD
Desipramine—CYP3A4—Vandetanib—thyroid cancer	0.0333	0.0467	CbGbCtD
Desipramine—CYP2D6—Sorafenib—thyroid cancer	0.0316	0.0443	CbGbCtD
Desipramine—ABCB1—Doxorubicin—thyroid cancer	0.0203	0.0285	CbGbCtD
Desipramine—CYP3A4—Sorafenib—thyroid cancer	0.0201	0.0282	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—thyroid cancer	0.0192	0.0269	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—thyroid cancer	0.0122	0.0171	CbGbCtD
Desipramine—SLC22A4—larynx—thyroid cancer	0.00987	0.161	CbGeAlD
Desipramine—Sudden death—Vandetanib—thyroid cancer	0.00678	0.0549	CcSEcCtD
Desipramine—SMPD1—thyroid gland—thyroid cancer	0.00264	0.043	CbGeAlD
Desipramine—SLC22A4—neck—thyroid cancer	0.00262	0.0426	CbGeAlD
Desipramine—SMPD1—head—thyroid cancer	0.00235	0.0382	CbGeAlD
Desipramine—Gynaecomastia—Sorafenib—thyroid cancer	0.00209	0.017	CcSEcCtD
Desipramine—Pollakiuria—Vandetanib—thyroid cancer	0.00201	0.0163	CcSEcCtD
Desipramine—CHRM4—head—thyroid cancer	0.002	0.0325	CbGeAlD
Desipramine—Depression—Vandetanib—thyroid cancer	0.00194	0.0157	CcSEcCtD
Desipramine—Stomatitis—Vandetanib—thyroid cancer	0.00189	0.0153	CcSEcCtD
Desipramine—SLC22A3—saliva-secreting gland—thyroid cancer	0.00186	0.0302	CbGeAlD
Desipramine—CHRM1—saliva-secreting gland—thyroid cancer	0.0018	0.0293	CbGeAlD
Desipramine—SMPD1—lymph node—thyroid cancer	0.00164	0.0267	CbGeAlD
Desipramine—CHRM3—saliva-secreting gland—thyroid cancer	0.00161	0.0262	CbGeAlD
Desipramine—SLC22A4—trachea—thyroid cancer	0.00157	0.0256	CbGeAlD
Desipramine—CHRM5—head—thyroid cancer	0.00156	0.0254	CbGeAlD
Desipramine—Arrhythmia—Vandetanib—thyroid cancer	0.00156	0.0126	CcSEcCtD
Desipramine—Alopecia—Vandetanib—thyroid cancer	0.00154	0.0125	CcSEcCtD
Desipramine—Dysgeusia—Vandetanib—thyroid cancer	0.00149	0.012	CcSEcCtD
Desipramine—Vision blurred—Vandetanib—thyroid cancer	0.00143	0.0116	CcSEcCtD
Desipramine—Tremor—Vandetanib—thyroid cancer	0.00142	0.0115	CcSEcCtD
Desipramine—CHRM1—trachea—thyroid cancer	0.00139	0.0226	CbGeAlD
Desipramine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00135	0.011	CcSEcCtD
Desipramine—SLC22A5—saliva-secreting gland—thyroid cancer	0.00135	0.022	CbGeAlD
Desipramine—Convulsion—Vandetanib—thyroid cancer	0.00131	0.0106	CcSEcCtD
Desipramine—Hypertension—Vandetanib—thyroid cancer	0.00131	0.0106	CcSEcCtD
Desipramine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00129	0.0105	CcSEcCtD
Desipramine—Anxiety—Vandetanib—thyroid cancer	0.00129	0.0104	CcSEcCtD
Desipramine—Myocardial infarction—Sorafenib—thyroid cancer	0.00128	0.0104	CcSEcCtD
Desipramine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00128	0.0104	CcSEcCtD
Desipramine—Stomatitis—Sorafenib—thyroid cancer	0.00128	0.0103	CcSEcCtD
Desipramine—Jaundice—Sorafenib—thyroid cancer	0.00128	0.0103	CcSEcCtD
Desipramine—Dry mouth—Vandetanib—thyroid cancer	0.00126	0.0102	CcSEcCtD
Desipramine—SLC22A4—thyroid gland—thyroid cancer	0.00125	0.0203	CbGeAlD
Desipramine—Oedema—Vandetanib—thyroid cancer	0.00124	0.01	CcSEcCtD
Desipramine—HTR2A—neck—thyroid cancer	0.00123	0.02	CbGeAlD
Desipramine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00121	0.00982	CcSEcCtD
Desipramine—SLC22A3—thyroid gland—thyroid cancer	0.00113	0.0184	CbGeAlD
Desipramine—Insomnia—Vandetanib—thyroid cancer	0.00112	0.00907	CcSEcCtD
Desipramine—Paraesthesia—Vandetanib—thyroid cancer	0.00111	0.009	CcSEcCtD
Desipramine—Tinnitus—Sorafenib—thyroid cancer	0.0011	0.00888	CcSEcCtD
Desipramine—Flushing—Sorafenib—thyroid cancer	0.00109	0.00883	CcSEcCtD
Desipramine—Dyspepsia—Vandetanib—thyroid cancer	0.00109	0.00883	CcSEcCtD
Desipramine—Decreased appetite—Vandetanib—thyroid cancer	0.00108	0.00872	CcSEcCtD
Desipramine—CHRM2—head—thyroid cancer	0.00107	0.0174	CbGeAlD
Desipramine—SLC6A3—head—thyroid cancer	0.00107	0.0174	CbGeAlD
Desipramine—Fatigue—Vandetanib—thyroid cancer	0.00107	0.00864	CcSEcCtD
Desipramine—Constipation—Vandetanib—thyroid cancer	0.00106	0.00857	CcSEcCtD
Desipramine—SLC22A1—head—thyroid cancer	0.00105	0.0171	CbGeAlD
Desipramine—Petechiae—Epirubicin—thyroid cancer	0.00105	0.00852	CcSEcCtD
Desipramine—Arrhythmia—Sorafenib—thyroid cancer	0.00105	0.0085	CcSEcCtD
Desipramine—SLC22A5—trachea—thyroid cancer	0.00104	0.017	CbGeAlD
Desipramine—Alopecia—Sorafenib—thyroid cancer	0.00104	0.00841	CcSEcCtD
Desipramine—HTR2C—head—thyroid cancer	0.00103	0.0168	CbGeAlD
Desipramine—ADRB1—head—thyroid cancer	0.00101	0.0165	CbGeAlD
Desipramine—SLC22A3—head—thyroid cancer	0.00101	0.0164	CbGeAlD
Desipramine—Dysgeusia—Sorafenib—thyroid cancer	0.001	0.00811	CcSEcCtD
Desipramine—CHRM3—thyroid gland—thyroid cancer	0.000984	0.016	CbGeAlD
Desipramine—Body temperature increased—Vandetanib—thyroid cancer	0.000979	0.00793	CcSEcCtD
Desipramine—Abdominal pain—Vandetanib—thyroid cancer	0.000979	0.00793	CcSEcCtD
Desipramine—SLC6A4—head—thyroid cancer	0.000979	0.0159	CbGeAlD
Desipramine—CHRM1—head—thyroid cancer	0.000975	0.0159	CbGeAlD
Desipramine—Petechiae—Doxorubicin—thyroid cancer	0.000973	0.00788	CcSEcCtD
Desipramine—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.000958	0.00776	CcSEcCtD
Desipramine—Nocturia—Epirubicin—thyroid cancer	0.000933	0.00755	CcSEcCtD
Desipramine—Atrioventricular block—Epirubicin—thyroid cancer	0.000892	0.00722	CcSEcCtD
Desipramine—Asthenia—Vandetanib—thyroid cancer	0.000888	0.00719	CcSEcCtD
Desipramine—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.000886	0.00718	CcSEcCtD
Desipramine—Hypertension—Sorafenib—thyroid cancer	0.000884	0.00715	CcSEcCtD
Desipramine—HRH1—trachea—thyroid cancer	0.000884	0.0144	CbGeAlD
Desipramine—Coordination abnormal—Epirubicin—thyroid cancer	0.000881	0.00713	CcSEcCtD
Desipramine—Pruritus—Vandetanib—thyroid cancer	0.000876	0.00709	CcSEcCtD
Desipramine—CHRM3—head—thyroid cancer	0.000873	0.0142	CbGeAlD
Desipramine—HTR1A—head—thyroid cancer	0.000869	0.0141	CbGeAlD
Desipramine—Ventricular tachycardia—Epirubicin—thyroid cancer	0.000865	0.00701	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.000865	0.00701	CcSEcCtD
Desipramine—Nocturia—Doxorubicin—thyroid cancer	0.000863	0.00699	CcSEcCtD
Desipramine—SLC6A2—head—thyroid cancer	0.000862	0.014	CbGeAlD
Desipramine—Dry mouth—Sorafenib—thyroid cancer	0.000852	0.0069	CcSEcCtD
Desipramine—Diarrhoea—Vandetanib—thyroid cancer	0.000847	0.00686	CcSEcCtD
Desipramine—Atrioventricular block—Doxorubicin—thyroid cancer	0.000825	0.00668	CcSEcCtD
Desipramine—SLC22A5—thyroid gland—thyroid cancer	0.000824	0.0134	CbGeAlD
Desipramine—Dizziness—Vandetanib—thyroid cancer	0.000819	0.00663	CcSEcCtD
Desipramine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000818	0.00662	CcSEcCtD
Desipramine—Coordination abnormal—Doxorubicin—thyroid cancer	0.000815	0.0066	CcSEcCtD
Desipramine—ORM1—lymph node—thyroid cancer	0.000804	0.0131	CbGeAlD
Desipramine—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.000801	0.00648	CcSEcCtD
Desipramine—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000801	0.00648	CcSEcCtD
Desipramine—Anorexia—Sorafenib—thyroid cancer	0.000796	0.00645	CcSEcCtD
Desipramine—Vomiting—Vandetanib—thyroid cancer	0.000787	0.00637	CcSEcCtD
Desipramine—DRD2—head—thyroid cancer	0.000785	0.0128	CbGeAlD
Desipramine—Rash—Vandetanib—thyroid cancer	0.000781	0.00632	CcSEcCtD
Desipramine—Dermatitis—Vandetanib—thyroid cancer	0.00078	0.00632	CcSEcCtD
Desipramine—Headache—Vandetanib—thyroid cancer	0.000776	0.00628	CcSEcCtD
Desipramine—SLC22A4—lymph node—thyroid cancer	0.000774	0.0126	CbGeAlD
Desipramine—CYP1A2—thyroid gland—thyroid cancer	0.000747	0.0122	CbGeAlD
Desipramine—HTR2A—trachea—thyroid cancer	0.000738	0.012	CbGeAlD
Desipramine—Nausea—Vandetanib—thyroid cancer	0.000736	0.00596	CcSEcCtD
Desipramine—Dyspepsia—Sorafenib—thyroid cancer	0.000735	0.00595	CcSEcCtD
Desipramine—Decreased appetite—Sorafenib—thyroid cancer	0.000726	0.00588	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000722	0.00585	CcSEcCtD
Desipramine—Fatigue—Sorafenib—thyroid cancer	0.00072	0.00583	CcSEcCtD
Desipramine—Constipation—Sorafenib—thyroid cancer	0.000714	0.00578	CcSEcCtD
Desipramine—SLC22A3—lymph node—thyroid cancer	0.000704	0.0115	CbGeAlD
Desipramine—Vascular purpura—Epirubicin—thyroid cancer	0.000702	0.00568	CcSEcCtD
Desipramine—CYP2E1—thyroid gland—thyroid cancer	0.000672	0.0109	CbGeAlD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000668	0.00541	CcSEcCtD
Desipramine—Urticaria—Sorafenib—thyroid cancer	0.000664	0.00537	CcSEcCtD
Desipramine—Abdominal pain—Sorafenib—thyroid cancer	0.00066	0.00535	CcSEcCtD
Desipramine—Body temperature increased—Sorafenib—thyroid cancer	0.00066	0.00535	CcSEcCtD
Desipramine—Purpura—Epirubicin—thyroid cancer	0.000652	0.00528	CcSEcCtD
Desipramine—Vascular purpura—Doxorubicin—thyroid cancer	0.00065	0.00526	CcSEcCtD
Desipramine—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000641	0.00519	CcSEcCtD
Desipramine—CYP2B6—head—thyroid cancer	0.000635	0.0103	CbGeAlD
Desipramine—HRH1—head—thyroid cancer	0.00062	0.0101	CbGeAlD
Desipramine—SLC6A2—lymph node—thyroid cancer	0.000603	0.00982	CbGeAlD
Desipramine—Purpura—Doxorubicin—thyroid cancer	0.000603	0.00488	CcSEcCtD
Desipramine—Asthenia—Sorafenib—thyroid cancer	0.000599	0.00485	CcSEcCtD
Desipramine—CYP2E1—head—thyroid cancer	0.000596	0.0097	CbGeAlD
Desipramine—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000593	0.0048	CcSEcCtD
Desipramine—Pruritus—Sorafenib—thyroid cancer	0.000591	0.00478	CcSEcCtD
Desipramine—Ataxia—Epirubicin—thyroid cancer	0.000591	0.00478	CcSEcCtD
Desipramine—Liver function test abnormal—Epirubicin—thyroid cancer	0.00058	0.00469	CcSEcCtD
Desipramine—Diarrhoea—Sorafenib—thyroid cancer	0.000572	0.00463	CcSEcCtD
Desipramine—Dizziness—Sorafenib—thyroid cancer	0.000552	0.00447	CcSEcCtD
Desipramine—Ataxia—Doxorubicin—thyroid cancer	0.000546	0.00442	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—thyroid cancer	0.000537	0.00435	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000537	0.00434	CcSEcCtD
Desipramine—Vomiting—Sorafenib—thyroid cancer	0.000531	0.0043	CcSEcCtD
Desipramine—Rash—Sorafenib—thyroid cancer	0.000527	0.00426	CcSEcCtD
Desipramine—Dermatitis—Sorafenib—thyroid cancer	0.000526	0.00426	CcSEcCtD
Desipramine—Headache—Sorafenib—thyroid cancer	0.000523	0.00424	CcSEcCtD
Desipramine—HTR2A—head—thyroid cancer	0.000518	0.00843	CbGeAlD
Desipramine—SLC22A5—lymph node—thyroid cancer	0.000512	0.00833	CbGeAlD
Desipramine—Pollakiuria—Epirubicin—thyroid cancer	0.000501	0.00406	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—thyroid cancer	0.000497	0.00403	CcSEcCtD
Desipramine—Nausea—Sorafenib—thyroid cancer	0.000496	0.00402	CcSEcCtD
Desipramine—Weight increased—Epirubicin—thyroid cancer	0.000494	0.004	CcSEcCtD
Desipramine—Drowsiness—Epirubicin—thyroid cancer	0.000484	0.00392	CcSEcCtD
Desipramine—ABCB1—trachea—thyroid cancer	0.000484	0.00787	CbGeAlD
Desipramine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000474	0.00384	CcSEcCtD
Desipramine—CYP2D6—head—thyroid cancer	0.000472	0.00768	CbGeAlD
Desipramine—Stomatitis—Epirubicin—thyroid cancer	0.000472	0.00382	CcSEcCtD
Desipramine—Jaundice—Epirubicin—thyroid cancer	0.000472	0.00382	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—thyroid cancer	0.000464	0.00376	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—thyroid cancer	0.000457	0.0037	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—thyroid cancer	0.000452	0.00366	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—thyroid cancer	0.000448	0.00363	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000439	0.00355	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—thyroid cancer	0.000437	0.00353	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—thyroid cancer	0.000437	0.00353	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—thyroid cancer	0.000435	0.00352	CcSEcCtD
Desipramine—HRH1—lymph node—thyroid cancer	0.000434	0.00707	CbGeAlD
Desipramine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000432	0.0035	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000418	0.00338	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—thyroid cancer	0.000405	0.00328	CcSEcCtD
Desipramine—Flushing—Epirubicin—thyroid cancer	0.000403	0.00326	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—thyroid cancer	0.000402	0.00326	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.0004	0.00324	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—thyroid cancer	0.000388	0.00314	CcSEcCtD
Desipramine—Alopecia—Epirubicin—thyroid cancer	0.000384	0.00311	CcSEcCtD
Desipramine—ABCB1—thyroid gland—thyroid cancer	0.000383	0.00623	CbGeAlD
Desipramine—Tinnitus—Doxorubicin—thyroid cancer	0.000375	0.00303	CcSEcCtD
Desipramine—Flushing—Doxorubicin—thyroid cancer	0.000373	0.00302	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—thyroid cancer	0.00037	0.003	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—thyroid cancer	0.000359	0.00291	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—thyroid cancer	0.000356	0.00289	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—thyroid cancer	0.000355	0.00288	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000351	0.00284	CcSEcCtD
Desipramine—Agitation—Epirubicin—thyroid cancer	0.000348	0.00281	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—thyroid cancer	0.000343	0.00277	CcSEcCtD
Desipramine—Malaise—Epirubicin—thyroid cancer	0.000341	0.00276	CcSEcCtD
Desipramine—ABCB1—head—thyroid cancer	0.000339	0.00552	CbGeAlD
Desipramine—Palpitations—Epirubicin—thyroid cancer	0.000334	0.00271	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—thyroid cancer	0.00033	0.00267	CcSEcCtD
Desipramine—Convulsion—Epirubicin—thyroid cancer	0.000328	0.00265	CcSEcCtD
Desipramine—Hypertension—Epirubicin—thyroid cancer	0.000327	0.00264	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000325	0.00263	CcSEcCtD
Desipramine—Agitation—Doxorubicin—thyroid cancer	0.000322	0.0026	CcSEcCtD
Desipramine—Anxiety—Epirubicin—thyroid cancer	0.000321	0.0026	CcSEcCtD
Desipramine—Discomfort—Epirubicin—thyroid cancer	0.000318	0.00258	CcSEcCtD
Desipramine—Malaise—Doxorubicin—thyroid cancer	0.000316	0.00256	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—thyroid cancer	0.000315	0.00255	CcSEcCtD
Desipramine—Confusional state—Epirubicin—thyroid cancer	0.000311	0.00252	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—thyroid cancer	0.000309	0.0025	CcSEcCtD
Desipramine—Oedema—Epirubicin—thyroid cancer	0.000309	0.0025	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—thyroid cancer	0.000303	0.00246	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000302	0.00245	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—thyroid cancer	0.000302	0.00245	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—thyroid cancer	0.000301	0.00244	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—thyroid cancer	0.000297	0.0024	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—thyroid cancer	0.000294	0.00238	CcSEcCtD
Desipramine—Anorexia—Epirubicin—thyroid cancer	0.000294	0.00238	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—thyroid cancer	0.000291	0.00236	CcSEcCtD
Desipramine—Hypotension—Epirubicin—thyroid cancer	0.000288	0.00234	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—thyroid cancer	0.000288	0.00233	CcSEcCtD
Desipramine—Oedema—Doxorubicin—thyroid cancer	0.000286	0.00231	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00028	0.00226	CcSEcCtD
Desipramine—Insomnia—Epirubicin—thyroid cancer	0.000279	0.00226	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—thyroid cancer	0.000279	0.00226	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—thyroid cancer	0.000277	0.00224	CcSEcCtD
Desipramine—Somnolence—Epirubicin—thyroid cancer	0.000274	0.00222	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—thyroid cancer	0.000272	0.0022	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—thyroid cancer	0.000272	0.0022	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—thyroid cancer	0.000268	0.00217	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—thyroid cancer	0.000267	0.00216	CcSEcCtD
Desipramine—Fatigue—Epirubicin—thyroid cancer	0.000266	0.00215	CcSEcCtD
Desipramine—Constipation—Epirubicin—thyroid cancer	0.000264	0.00214	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—thyroid cancer	0.000258	0.00209	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—thyroid cancer	0.000256	0.00208	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—thyroid cancer	0.000254	0.00206	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—thyroid cancer	0.000254	0.00206	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—thyroid cancer	0.000251	0.00204	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—thyroid cancer	0.000248	0.00201	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—thyroid cancer	0.000246	0.00199	CcSEcCtD
Desipramine—Urticaria—Epirubicin—thyroid cancer	0.000245	0.00199	CcSEcCtD
Desipramine—Constipation—Doxorubicin—thyroid cancer	0.000244	0.00198	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—thyroid cancer	0.000244	0.00198	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—thyroid cancer	0.000244	0.00198	CcSEcCtD
Desipramine—ABCB1—lymph node—thyroid cancer	0.000238	0.00387	CbGeAlD
Desipramine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000235	0.00191	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—thyroid cancer	0.000227	0.00184	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—thyroid cancer	0.000226	0.00183	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—thyroid cancer	0.000226	0.00183	CcSEcCtD
Desipramine—Asthenia—Epirubicin—thyroid cancer	0.000221	0.00179	CcSEcCtD
Desipramine—Pruritus—Epirubicin—thyroid cancer	0.000218	0.00177	CcSEcCtD
Desipramine—Diarrhoea—Epirubicin—thyroid cancer	0.000211	0.00171	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—thyroid cancer	0.000205	0.00166	CcSEcCtD
Desipramine—Dizziness—Epirubicin—thyroid cancer	0.000204	0.00165	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—thyroid cancer	0.000202	0.00164	CcSEcCtD
Desipramine—Vomiting—Epirubicin—thyroid cancer	0.000196	0.00159	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—thyroid cancer	0.000195	0.00158	CcSEcCtD
Desipramine—Rash—Epirubicin—thyroid cancer	0.000195	0.00158	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—thyroid cancer	0.000194	0.00157	CcSEcCtD
Desipramine—Headache—Epirubicin—thyroid cancer	0.000193	0.00157	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—thyroid cancer	0.000189	0.00153	CcSEcCtD
Desipramine—Nausea—Epirubicin—thyroid cancer	0.000183	0.00148	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—thyroid cancer	0.000182	0.00147	CcSEcCtD
Desipramine—Rash—Doxorubicin—thyroid cancer	0.00018	0.00146	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—thyroid cancer	0.00018	0.00146	CcSEcCtD
Desipramine—Headache—Doxorubicin—thyroid cancer	0.000179	0.00145	CcSEcCtD
Desipramine—Nausea—Doxorubicin—thyroid cancer	0.00017	0.00137	CcSEcCtD
Desipramine—HTR2C—Signaling Pathways—NRG1—thyroid cancer	2.1e-05	0.000205	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—NRAS—thyroid cancer	2.03e-05	0.000199	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—TPR—thyroid cancer	2.01e-05	0.000197	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—PTEN—thyroid cancer	2e-05	0.000196	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TERT—thyroid cancer	1.98e-05	0.000194	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.98e-05	0.000194	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—NRAS—thyroid cancer	1.95e-05	0.000191	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TERT—thyroid cancer	1.93e-05	0.000189	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.93e-05	0.000189	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—BRAF—thyroid cancer	1.91e-05	0.000187	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TERT—thyroid cancer	1.89e-05	0.000185	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—PTEN—thyroid cancer	1.89e-05	0.000185	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HIF1A—thyroid cancer	1.89e-05	0.000185	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.88e-05	0.000185	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TERT—thyroid cancer	1.88e-05	0.000184	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HIF1A—thyroid cancer	1.85e-05	0.000181	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRG1—thyroid cancer	1.85e-05	0.000181	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PPARG—thyroid cancer	1.83e-05	0.000179	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—BRAF—thyroid cancer	1.83e-05	0.000179	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRG1—thyroid cancer	1.82e-05	0.000178	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRG1—thyroid cancer	1.82e-05	0.000178	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRG1—thyroid cancer	1.81e-05	0.000177	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.81e-05	0.000177	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	1.81e-05	0.000177	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRG1—thyroid cancer	1.8e-05	0.000177	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	1.8e-05	0.000176	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.79e-05	0.000176	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRG1—thyroid cancer	1.79e-05	0.000175	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.78e-05	0.000174	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—KRAS—thyroid cancer	1.75e-05	0.000171	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PPARG—thyroid cancer	1.71e-05	0.000167	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PPARG—thyroid cancer	1.68e-05	0.000165	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—KRAS—thyroid cancer	1.67e-05	0.000164	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—NRAS—thyroid cancer	1.67e-05	0.000163	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TERT—thyroid cancer	1.66e-05	0.000163	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TERT—thyroid cancer	1.63e-05	0.00016	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TERT—thyroid cancer	1.63e-05	0.00016	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—NRAS—thyroid cancer	1.63e-05	0.00016	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TERT—thyroid cancer	1.63e-05	0.000159	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—RXRA—thyroid cancer	1.62e-05	0.000159	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TERT—thyroid cancer	1.62e-05	0.000159	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TERT—thyroid cancer	1.6e-05	0.000157	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.59e-05	0.000156	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	1.59e-05	0.000156	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	1.59e-05	0.000155	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—RXRA—thyroid cancer	1.58e-05	0.000155	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.58e-05	0.000155	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PPARG—thyroid cancer	1.58e-05	0.000154	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—BRAF—thyroid cancer	1.57e-05	0.000153	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.56e-05	0.000153	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HIF1A—thyroid cancer	1.56e-05	0.000153	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HIF1A—thyroid cancer	1.55e-05	0.000152	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TPR—thyroid cancer	1.55e-05	0.000152	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HIF1A—thyroid cancer	1.55e-05	0.000152	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HIF1A—thyroid cancer	1.53e-05	0.00015	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—BRAF—thyroid cancer	1.53e-05	0.00015	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.53e-05	0.000149	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.5e-05	0.000147	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.5e-05	0.000147	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.49e-05	0.000146	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.49e-05	0.000146	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—HRAS—thyroid cancer	1.49e-05	0.000146	CbGpPWpGaD
Desipramine—CHRM4—GPCR downstream signaling—AKT1—thyroid cancer	1.44e-05	0.000142	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PTGS2—thyroid cancer	1.44e-05	0.000141	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—KRAS—thyroid cancer	1.43e-05	0.00014	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—HRAS—thyroid cancer	1.42e-05	0.000139	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.41e-05	0.000138	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—KRAS—thyroid cancer	1.4e-05	0.000137	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.4e-05	0.000137	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—CCND1—thyroid cancer	1.39e-05	0.000136	CbGpPWpGaD
Desipramine—CHRM5—GPCR downstream signaling—AKT1—thyroid cancer	1.38e-05	0.000136	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.38e-05	0.000135	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.37e-05	0.000135	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.37e-05	0.000134	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	1.37e-05	0.000134	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—NRAS—thyroid cancer	1.37e-05	0.000134	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.36e-05	0.000134	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PPARG—thyroid cancer	1.36e-05	0.000133	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	1.35e-05	0.000132	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PTEN—thyroid cancer	1.34e-05	0.000132	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PTGS2—thyroid cancer	1.34e-05	0.000131	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—CCND1—thyroid cancer	1.33e-05	0.000131	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PPARG—thyroid cancer	1.33e-05	0.00013	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PTGS2—thyroid cancer	1.32e-05	0.000129	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.32e-05	0.000129	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—AKT1—thyroid cancer	1.31e-05	0.000129	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.29e-05	0.000127	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.29e-05	0.000126	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PTEN—thyroid cancer	1.29e-05	0.000126	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—BRAF—thyroid cancer	1.29e-05	0.000126	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—BRAF—thyroid cancer	1.28e-05	0.000126	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—BRAF—thyroid cancer	1.27e-05	0.000124	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—RXRA—thyroid cancer	1.26e-05	0.000124	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—AKT1—thyroid cancer	1.26e-05	0.000123	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PTEN—thyroid cancer	1.26e-05	0.000123	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTGS2—thyroid cancer	1.24e-05	0.000121	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.23e-05	0.00012	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—HRAS—thyroid cancer	1.22e-05	0.000119	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.2e-05	0.000118	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NRAS—thyroid cancer	1.2e-05	0.000118	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—HRAS—thyroid cancer	1.19e-05	0.000117	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—AKT1—thyroid cancer	1.19e-05	0.000116	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.19e-05	0.000116	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.18e-05	0.000116	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	1.18e-05	0.000115	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	1.18e-05	0.000115	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PTEN—thyroid cancer	1.17e-05	0.000115	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.17e-05	0.000114	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	1.16e-05	0.000114	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.16e-05	0.000114	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.16e-05	0.000114	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—AKT1—thyroid cancer	1.16e-05	0.000114	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—AKT1—thyroid cancer	1.15e-05	0.000113	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PTEN—thyroid cancer	1.15e-05	0.000113	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NRAS—thyroid cancer	1.15e-05	0.000113	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CCND1—thyroid cancer	1.14e-05	0.000112	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.13e-05	0.000111	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.13e-05	0.00011	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CCND1—thyroid cancer	1.12e-05	0.00011	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PTEN—thyroid cancer	1.1e-05	0.000108	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.09e-05	0.000107	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—thyroid cancer	1.09e-05	0.000107	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.09e-05	0.000107	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTEN—thyroid cancer	1.08e-05	0.000106	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PTEN—thyroid cancer	1.08e-05	0.000106	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—thyroid cancer	1.08e-05	0.000105	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.07e-05	0.000104	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.06e-05	0.000103	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—thyroid cancer	1.05e-05	0.000103	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.05e-05	0.000103	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.04e-05	0.000102	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KRAS—thyroid cancer	1.03e-05	0.000101	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.03e-05	0.000101	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.02e-05	0.0001	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.02e-05	0.0001	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.02e-05	0.0001	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.01e-05	9.87e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.01e-05	9.85e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	1e-05	9.81e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—thyroid cancer	1e-05	9.79e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	9.99e-06	9.78e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	9.95e-06	9.75e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	9.89e-06	9.69e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KRAS—thyroid cancer	9.89e-06	9.69e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NRAS—thyroid cancer	9.84e-06	9.64e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	9.79e-06	9.59e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	9.77e-06	9.57e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—RXRA—thyroid cancer	9.76e-06	9.56e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	9.74e-06	9.54e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	9.71e-06	9.51e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NRAS—thyroid cancer	9.63e-06	9.43e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	9.62e-06	9.42e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—thyroid cancer	9.6e-06	9.4e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—thyroid cancer	9.45e-06	9.25e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—thyroid cancer	9.43e-06	9.23e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—thyroid cancer	9.42e-06	9.23e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—thyroid cancer	9.42e-06	9.22e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—thyroid cancer	9.4e-06	9.2e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—thyroid cancer	9.37e-06	9.17e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—thyroid cancer	9.37e-06	9.17e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—thyroid cancer	9.3e-06	9.11e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	9.27e-06	9.08e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—thyroid cancer	9.27e-06	9.08e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—thyroid cancer	9.18e-06	8.99e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—thyroid cancer	9.12e-06	8.93e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—thyroid cancer	9.11e-06	8.92e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—thyroid cancer	9.1e-06	8.91e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—thyroid cancer	9.07e-06	8.88e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	9.04e-06	8.85e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—thyroid cancer	9.04e-06	8.85e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	8.95e-06	8.77e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	8.89e-06	8.71e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—thyroid cancer	8.88e-06	8.69e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	8.85e-06	8.67e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	8.82e-06	8.64e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—thyroid cancer	8.79e-06	8.61e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—thyroid cancer	8.78e-06	8.6e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	8.73e-06	8.55e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—thyroid cancer	8.47e-06	8.3e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—thyroid cancer	8.41e-06	8.23e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—thyroid cancer	8.29e-06	8.12e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—thyroid cancer	8.27e-06	8.1e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—thyroid cancer	8.13e-06	7.97e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—thyroid cancer	8.12e-06	7.95e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—thyroid cancer	8.1e-06	7.94e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—thyroid cancer	8.09e-06	7.92e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—thyroid cancer	8.06e-06	7.9e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—thyroid cancer	8.06e-06	7.9e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—thyroid cancer	8.06e-06	7.89e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	7.99e-06	7.82e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—thyroid cancer	7.98e-06	7.82e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—thyroid cancer	7.87e-06	7.7e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—thyroid cancer	7.75e-06	7.59e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—thyroid cancer	7.53e-06	7.38e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—thyroid cancer	7.42e-06	7.27e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.41e-06	7.26e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—thyroid cancer	7.37e-06	7.21e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—thyroid cancer	7.24e-06	7.09e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—thyroid cancer	7.2e-06	7.05e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—thyroid cancer	7.2e-06	7.05e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—thyroid cancer	7.17e-06	7.02e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—thyroid cancer	7.12e-06	6.97e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—thyroid cancer	7.04e-06	6.9e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—thyroid cancer	7.03e-06	6.88e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—thyroid cancer	7e-06	6.86e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—thyroid cancer	6.99e-06	6.84e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—thyroid cancer	6.96e-06	6.82e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—thyroid cancer	6.94e-06	6.8e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—thyroid cancer	6.89e-06	6.75e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	6.87e-06	6.73e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—thyroid cancer	6.86e-06	6.72e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—thyroid cancer	6.85e-06	6.71e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—thyroid cancer	6.74e-06	6.61e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—thyroid cancer	6.64e-06	6.51e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—thyroid cancer	6.46e-06	6.33e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—thyroid cancer	6.36e-06	6.23e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—thyroid cancer	6.32e-06	6.19e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—thyroid cancer	6.28e-06	6.15e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—thyroid cancer	6.23e-06	6.1e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—thyroid cancer	6.22e-06	6.09e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—thyroid cancer	6.22e-06	6.09e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—thyroid cancer	6.21e-06	6.08e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—thyroid cancer	6.19e-06	6.06e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—thyroid cancer	6.17e-06	6.04e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—thyroid cancer	6.16e-06	6.03e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—thyroid cancer	6.11e-06	5.98e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—thyroid cancer	6.08e-06	5.96e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—thyroid cancer	6.05e-06	5.93e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—thyroid cancer	6.05e-06	5.92e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—thyroid cancer	5.95e-06	5.83e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—thyroid cancer	5.94e-06	5.82e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—thyroid cancer	5.92e-06	5.8e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—thyroid cancer	5.9e-06	5.78e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	5.84e-06	5.72e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—thyroid cancer	5.48e-06	5.36e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—thyroid cancer	5.36e-06	5.25e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—thyroid cancer	5.34e-06	5.23e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—thyroid cancer	5.25e-06	5.15e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—thyroid cancer	5.25e-06	5.14e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—thyroid cancer	5.24e-06	5.14e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—thyroid cancer	5.23e-06	5.12e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—thyroid cancer	5.21e-06	5.1e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	5.16e-06	5.05e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.85e-06	4.75e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—thyroid cancer	4.23e-06	4.14e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—thyroid cancer	4.05e-06	3.97e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—thyroid cancer	3.95e-06	3.87e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.73e-06	3.65e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—thyroid cancer	3.16e-06	3.09e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.44e-06	2.39e-05	CbGpPWpGaD
